Miraculins Updates Market on Distributor Discussions for Scout DS(R) Diabetes Screening Test in China
02 Mai 2014 - 12:30PM
Marketwired
Miraculins Updates Market on Distributor Discussions for Scout
DS(R) Diabetes Screening Test in China
WINNIPEG, MANITOBA--(Marketwired - May 2, 2014) - Miraculins
Inc. (TSX-VENTURE:MOM) ("Miraculins" or the "Company"), a medical
diagnostic company focused on acquiring, developing and
commercializing diagnostic tests and risk assessment technologies
for unmet clinical needs, today announces that the Company
continues to advance discussions towards finalizing an agreement
(the "Agreement") that would see the Scout DS® test distributed
exclusively in China by Cachet Pharmaceutical Co., Ltd.
("Cachet").
"I recently completed meetings in Beijing with Cachet's senior
executive management team and our Shanghai-based legal counsel. I
am pleased to report that the parties have significantly advanced
discussions towards the finalization of the Agreement and signing
of all definitive documentation," said Christopher J. Moreau,
President and CEO of Miraculins Inc.
The completion of the Agreement and execution of definitive
documentation remain subject to all necessary contractual,
regulatory and corporate approvals of both Miraculins and Cachet
and the completion of satisfactory due diligence. There is no
assurance that the parties will enter into the Agreement or execute
the definitive documentation.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Caution Regarding Forward-Looking Information
Certain statements contained in this press release
constitute forward-looking information within the meaning of
applicable Canadian provincial securities legislation
(collectively, "forward-looking statements"). These forward-looking
statements include statements regarding the completion of
definitive documentation and the execution of the Agreement. These
forward-looking statements relate to, among other things, our
objectives, goals, targets, strategies, intentions, plans, beliefs,
estimates and outlook, including, without limitation, our
anticipated future operating results, and can, in some cases, be
identified by the use of words such as "believe",
"anticipate", "expect", "intend",
"plan", "will", "may" and other similar
expressions. In addition, any statements that refer to
expectations, projections or other characterizations of future
events or circumstances are forward-looking statements.
These statements reflect management's current beliefs and
are based on information currently available to management. Certain
material factors or assumptions are applied in making
forward-looking statements, and actual results may differ
materially from those expressed or implied in such statements.
Important factors that could cause actual results to differ
materially from these expectations include, among other things:
Miraculins' early stage of development, lack of product revenues
and history of operating losses, uncertainties related to clinical
trials and product development, rapid technological change,
uncertainties related to forecasts, competition, potential product
liability, additional financing requirements and access to capital,
unproven markets, supply of raw materials, income tax matters,
management of growth, partnerships for development and
commercialization of technology, effects of insurers' willingness
to pay for products, system failures, dependence on key personnel,
foreign currency risk, risks related to regulatory matters and
risks related to intellectual property and other risks detailed
from time to time in Miraculins' filings with Canadian securities
regulatory authorities, as well as Miraculins' ability to
anticipate and manage the risks associated with the foregoing.
Additional information about these factors and about the material
factors or assumptions underlying such forward-looking statements
may be found in the body of this news release. Miraculins cautions
that the foregoing list of important factors that may affect future
results is not exhaustive. When relying on Miraculins'
forward-looking statements to make decisions with respect to
Miraculins investors and others should carefully consider the
foregoing factors and other uncertainties and potential
events.
These risks and uncertainties should be considered carefully
and prospective investors should not place undue reliance on the
forward-looking statements. Although the forward-looking statements
contained in this press release are based upon what management
believes to be reasonable assumptions, Miraculins cannot provide
assurance that actual results will be consistent with these
forward-looking statements. Miraculins undertakes no obligation to
update or revise any forward-looking statements.
Scout DS® is a registered trademark of
Miraculins Inc. All Rights Reserved. 2014.
Miraculins Inc.Christopher J. MoreauPresident &
CEO204-477-7599204-453-1546info@miraculins.comwww.miraculins.com
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Jul 2023 bis Jul 2024